Michael LaCascia - 30 Jan 2026 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Legal Officer
Signature
/s/Samantha Macina, as attorney in fact for Michael LaCascia
Issuer symbol
FHTX
Transactions as of
30 Jan 2026
Net transactions value
+$1,684,450
Form type
4
Filing time
02 Feb 2026, 16:03:48 UTC
Previous filing
24 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LaCascia Michael Chief Legal Officer 99 COOLIDGE AVENUE, SUITE 500, WATERTOWN /s/Samantha Macina, as attorney in fact for Michael LaCascia 02 Feb 2026 0001831755

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock option (right to buy) Award $1,684,450 +295,000 $5.71 295,000 30 Jan 2026 Common Stock 295,000 $5.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of common stock on January 30, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.